コレステロールスクリーニング/コレステロール臨床試験の世界市場予測（～2021）：サービス利用者別（医師/医療提供者、病院、雇用主、医療制度、MCO、政府、ACO、IDN総合医療ネットワーク、患者）、地域別（北米、ヨーロッパ）、定性的評価...市場調査レポートについてご紹介

TABLE OF CONTENTS

1. INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET INTRODUCTION
1.3 MARKET DEFINITION
1.4 MARKET SCOPE
1.5 YEARS CONSIDERED FOR THE STUDY
1.6 LIMITATIONS
1.7 STAKEHOLDERS
2. RESEARCH METHODOLOGY
2.1 MARKET SIZE ESTIMATION
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.3 KEY DATA FROM SECONDARY SOURCES
2.4 KEY DATA FROM PRIMARY SOURCES
2.5 ASSUMPTIONS
3. EXECUTIVE SUMMARY
4. PREMIUM INSIGHTS
4.1 MARKET OVERVIEW
4.2 CHOLESTEROL TESTING SERVICES MARKET, BY TYPE OF CUSTOMER
4.3 GEOGRAPHIC SNAPSHOT: CHOLESTEROL TESTING SERVICES MARKET
5. INDUSTRY INSIGHTS
5.1 COST STRUCTURE & PRICING ANALYSIS
5.2 REIMBURSEMENT SCENARIO
6. MARKET DYNAMICS
6.1 INTRODUCTION
6.2 MARKET DRIVERS
6.2.1 Increasing incidence of cardiovascular diseases (CVDs) and obesity
6.2.2 Physician’s preference for lab testing over self-testing
6.2.3 Growing awareness and adoption of preventive healthcare
6.2.4 Government initiatives to improve quality of testing
6.2.5 Rapid growth in the geriatric population
6.2 MARKET RESTRAINTS
6.3.1 Rapidly growing cholesterol home/self-testing market
6.3.2 Emergence of noninvasive cholesterol testing methods
6.3 MARKET OPPORTUNITIES
6.4.1 High growth potential in emerging economies
6.4.2 Patient-initiated testing to foster market growth in developed countries
6.4 MARKET CHALLENGES
6.5.1 Patient data security
6.5.2 Evolving regulatory policies
7. NON-PHARMACOLOGICAL TREATMENT MARKET
6.1 INTRODUCTION
6.1.1 COGNITIVE BEHAVIORAL THERAPY FOR INSOMNIA (CBTI)
6.1.2 HYPNOTHERAPY
6.1.3 OTHER ALTERNATIVE THERAPIES
6.2 THERAPY RECOMMENDATION, 2015 (%)
6.3 QUALITATIVE ASSESSMENT
7. CHOLESTEROL TESTING/CHOLESTEROL SCREENING SERVICES MARKET, BY TYPE OF CUSTOMER
7.1 PHYSICIANS/PROVIDERS AND HOSPITALS
7.2 EMPLOYERS, HEALTH PLANS, AND MANAGED CARE ORGANIZATIONS (MCOS)
7.3 GOVERNMENT AGENCIES, ACCOUNTABLE CARE ORGANIZATIONS, AND INTEGRATED DELIVERY NETWORKS (IDNS)
7.4 PATIENTS

8 . REGIONAL ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 U.S.
8.2.2 CANADA
8.3 EUROPE
8.3.1 U.K.
8.3.2 GERMANY
8.3.3 FRANCE
8.3.4 ITALY
8.3.5 SPAIN
8.3.6 REST OF EUROPE
8.4 ASIA
8.5 REST OF THE WORLD
9. COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 MARKET SHARE ANALYSIS
9.3 COMPETITIVE SITUATION AND TRENDS
9.3.1 ACQUISITIONS
9.3.2 EXPANSIONS AND INVESTMENTS
9.3.3 AGREEMENTS
9.3.4 SERVICE LAUNCHES
10. COMPANY PROFILES
10.1 LABORATORY CORPORATION OF AMERICA HOLDINGS (LABCORP)
10.2 QUEST DIAGNOSTICS INCORPORATED
10.3 EUROFINS SCIENTIFIC
10.4 SPECTRA LABORATORIES, INC.
10.5 UNILABS
10.6 SYNLAB INTERNATIONAL GMBH
10.7 BIO-REFERENCE LABORATORIES, INC.
10.8 CLINICAL REFERENCE LABORATORY, INC.
10.9 ACM MEDICAL LABORATORY)
10.10 ADICON CLINICAL LABORATORY
11. APPENDIX
11.1 KEY INDUSTRY INSIGHTS
11.2 DISCUSSION GUIDE
11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
11.5 RELATED REPORTS